Endpoints Manufacturing: 5 Questions with Homology Medicines
This week, I asked five questions of Tim Kelly, the chief technology officer at Homology Medicines. Kelly has over two decades of experience in manufacturing, having spent time at Sarepta and Shire before joining Homology.
The Bedford, MA company is seeking to harness a novel technology that uses AAV vectors derived from human hematopoietic stem cells that are designed to precisely and efficiently deliver genetic medicines into the human body. Part of Kelly’s tenure has included construction of the company’s in-house manufacturing facility.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,900+ biopharma pros reading Endpoints daily — and it's free.